Literature DB >> 27356834

Response to Savarino et al.

Somchai Leelakusolvong1, Julajak Limsrivilai1, Phunchai Charatcharoenwitthaya1, Nonthalee Pausawasdi1.   

Abstract

Year:  2016        PMID： 27356834     DOI： 10.1038/ajg.2016.203

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  6 in total

1.  Treatment of patients with persistent heartburn symptoms: a double-blind, randomized trial.

Authors:  Ronnie Fass; Stephen J Sontag; Barry Traxler; Mark Sostek
Journal:  Clin Gastroenterol Hepatol       Date:  2006-01       Impact factor: 11.382

2.  Imipramine for Treatment of Esophageal Hypersensitivity and Functional Heartburn: A Randomized Placebo-Controlled Trial.

Authors:  Julajak Limsrivilai; Phunchai Charatcharoenwitthaya; Nonthalee Pausawasdi; Somchai Leelakusolvong
Journal:  Am J Gastroenterol       Date:  2016-01-12       Impact factor: 10.864

3.  Tryciclic Antidepressants in Refractory GERD: Poorly Effective Drugs or Wrong Patients?

Authors:  Edoardo Savarino; Manuele Furnari; Giorgia Bodini; Vincenzo Savarino
Journal:  Am J Gastroenterol       Date:  2016-07       Impact factor: 10.864

4.  Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Impedance-pH Monitoring of Patients With Reflux Disease.

Authors:  Marzio Frazzoni; Edoardo Savarino; Nicola de Bortoli; Irene Martinucci; Manuele Furnari; Leonardo Frazzoni; Vincenzo Giorgio Mirante; Helga Bertani; Santino Marchi; Rita Conigliaro; Vincenzo Savarino
Journal:  Clin Gastroenterol Hepatol       Date:  2015-06-26       Impact factor: 11.382

5.  Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro-oesophageal reflux disease (GERD) who are resistant to conventional-dose lansoprazole therapy-a prospective, randomized, multi-centre study.

Authors:  R Fass; U Murthy; C W Hayden; I B Malagon; G Pulliam; C Wendel; T O Kovacs
Journal:  Aliment Pharmacol Ther       Date:  2000-12       Impact factor: 8.171

6.  Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease.

Authors:  James C Slaughter; Marion Goutte; Jennifer A Rymer; Amanke C Oranu; Jonathan A Schneider; C Gaelyn Garrett; David Hagaman; Michael F Vaezi
Journal:  Clin Gastroenterol Hepatol       Date:  2011-07-23       Impact factor: 11.382
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.